Lonza Chooses Synpromics’ Novel Inducible Promoter Platform to Manufacture Biopharmaceuticals
Synpromics Ltd, the leader in gene control, and Lonza Pharma & Biotech announce a partnership for the commercialization of a number of inducible promoters to improve the…
Read More...
Read More...
